ARTICLE | Clinical News
Ketek telithromycin: Phase III suspended enrollment
June 12, 2006 7:00 AM UTC
SAN said it voluntarily suspended enrollment in a pediatric trial for Ketek to await FDA confirmation that the development program is consistent with the agency’s "current thinking" on development of ...